] i in electrically stimulated cardiomyocytes (16). In contrast, the norepinephrine-mediated potentiation of the ATP response in quiescent cardiomyocytes has been reported to be independent of Ca 2ϩ release from the SR Ca 2ϩ stores (9). It has been shown that the stimulation of ␤-ARs by isoproterenol causes an increase in the SL Na ϩ /Ca 2ϩ exchange activity in guinea pig ventricular cardiomyocytes (22) and rabbit Purkinje fibers (13). On the other hand, in frog atrial fibers and ventricular cardiomyocytes, an increase (23) or decrease (12) in Na ϩ /Ca 2ϩ exchange activity was observed on stimulation by isoproterenol, respectively. Nonetheless, the participation of Na ϩ /Ca 2ϩ exchange in the catecholamine-mediated increase in ATP response in rat ventricular cardiomyocytes is not known. Accordingly, the present study was undertaken to test the hypothesis that SL Na ϩ /Ca 2ϩ exchanger is involved in the isoproterenol-mediated stimulation of the ATP-induced intracellular Ca 2ϩ mobilization. For this purpose, fura-2 AMloaded isolated rat cardiomyocytes were treated with isoproterenol, a ␤-AR agonist (26), in the absence or presence of different antagonists of SL Na ϩ /Ca 2ϩ exchanger before the addition of ATP. In addition, the effects of other agents that are known to modify Ca 2ϩ transport in both SL and SR (24, 33) were tested to gain some information regarding the participation of different sites in the catecholamine-induced increase in [Ca 2ϩ ] i in cardiomyocytes. Because low Na ϩ has been shown to stimulate the SL Na ϩ /Ca 2ϩ exchange activity in isolated cardiomyocytes (24), some experiments were also performed in the presence of low Na ϩ to further confirm the contribution of Na ϩ /Ca 2ϩ exchanger in the catecholamine-mediated increase in [Ca 2ϩ ] i . The effect of KB-R7943, an inhibitor of SL Na ϩ /Ca 2ϩ exchanger (28), on the positive inotropic action of isoproterenol was investigated by employing isolated rat heart preparations.
]i is not fully understood. To gain some information in this regard, isolated rat cardiomyocytes were treated with different agents, which are known to modify Ca 2ϩ movements, in the absence or presence of a ␤-adrenoceptor agonist, isoproterenol, and [Ca 2ϩ ]i in cardiomyocytes was determined spectrofluorometrically with fura-2 AM. Treatment with isoproterenol did not alter [Ca 2ϩ ] i in quiescent cardiomyocytes, whereas the ATP (purinergic receptor agonist)-induced increase in [Ca 2ϩ ]i was significantly potentiated by isoproterenol. Unlike ryanodine and cyclopiazonic acid, which affect the sarcoplasmic reticulum function, SL L-type Ca 2ϩ channel blockers verapamil and diltiazem, as well as a SL Ca 2ϩ -pump inhibitor, vanadate, caused a significant depression in the isoproterenol-induced increase in [Ca 2ϩ ]i. The SL Na ϩ /Ca 2ϩ exchange blockers amiloride, Ni 2ϩ , and KB-R7943 also attenuated the isoproterenol-mediated increase in [Ca 2ϩ ]i. Combination of KB-R7943 and verapamil showed additive inhibitory effects on the isoproterenol-induced increase in [Ca 2ϩ ]i. The isoproterenol-induced increase in [Ca 2ϩ ]i in KCl-depolarized cardiomyocytes was augmented by low Na ϩ ; this augmentation was significantly depressed by treatment with KB-R7943. The positive inotropic action of isoproterenol in isolated hearts was also reduced by KB-R7943. These data suggest that in addition to SL L-type Ca 2ϩ channels, SL Na ϩ /Ca 2ϩ exchanger seems to play an important role in catecholamine-induced increase in [Ca 2ϩ ]i in cardiomyocytes.
sodium/calcium exchanger; L-type calcium channels; calcium-pump adenosine triphosphatase; calcium-release channels; cardiomyocyte calcium handling IT IS NOW WELL KNOWN that, unlike quiescent cardiomyocytes, the stimulation of ␤-adrenoceptors (␤-ARs) by catecholamines causes a marked increase in the intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ) in electrically stimulated (35) or KCl-depolarized cardiomyocytes (26) . On the other hand, the stimulation of purinergic receptors by extracellular ATP augments [Ca 2ϩ ] i in quiescent cardiomyocytes (8, 27) . Previous studies by De Young and Scarpa (9, 10) have shown that ATP-induced increase in [Ca 2ϩ ] i is potentiated by norepinephrine. This increase of the ATP response by norepinephrine treatment has been demonstrated to be due to Ca 2ϩ entry through the sarcolemmal (SL) L-type Ca 2ϩ channels. In this regard, it is pointed out that norepinephrine and other catecholamines, including isoproterenol, have been shown to phosphorylate the L-type Ca 2ϩ channels and enhance the inward Ca 2ϩ current as a consequence of increased production of cAMP and the activation of protein kinase A (PKA) (36, 37) . The increased Ca 2ϩ entry through the SL membrane further triggers the release of Ca 2ϩ from the sarcoplasmic reticulum (SR) stores and thus results in the catecholamine-mediated increase in [Ca 2ϩ ] i in electrically stimulated cardiomyocytes (16) . In contrast, the norepinephrine-mediated potentiation of the ATP response in quiescent cardiomyocytes has been reported to be independent of Ca 2ϩ release from the SR Ca 2ϩ stores (9) . It has been shown that the stimulation of ␤-ARs by isoproterenol causes an increase in the SL Na ϩ /Ca 2ϩ exchange activity in guinea pig ventricular cardiomyocytes (22) and rabbit Purkinje fibers (13) . On the other hand, in frog atrial fibers and ventricular cardiomyocytes, an increase (23) or decrease (12) in Na ϩ /Ca 2ϩ exchange activity was observed on stimulation by isoproterenol, respectively. Nonetheless, the participation of Na ϩ /Ca 2ϩ exchange in the catecholamine-mediated increase in ATP response in rat ventricular cardiomyocytes is not known. Accordingly, the present study was undertaken to test the hypothesis that SL Na ϩ /Ca 2ϩ exchanger is involved in the isoproterenol-mediated stimulation of the ATP-induced intracellular Ca 2ϩ mobilization. For this purpose, fura-2 AMloaded isolated rat cardiomyocytes were treated with isoproterenol, a ␤-AR agonist (26) , in the absence or presence of different antagonists of SL Na ϩ /Ca 2ϩ exchanger before the addition of ATP. In addition, the effects of other agents that are known to modify Ca 2ϩ transport in both SL and SR (24, 33) were tested to gain some information regarding the participation of different sites in the catecholamine-induced increase in [Ca 2ϩ ] i in cardiomyocytes. Because low Na ϩ has been shown to stimulate the SL Na ϩ /Ca 2ϩ exchange activity in isolated cardiomyocytes (24) , some experiments were also performed in the presence of low Na ϩ to further confirm the contribution of Na ϩ /Ca 2ϩ exchanger in the catecholamine-mediated increase in [Ca 2ϩ ] i . The effect of KB-R7943, an inhibitor of SL Na ϩ /Ca 2ϩ exchanger (28) , on the positive inotropic action of isoproterenol was investigated by employing isolated rat heart preparations.
METHODS
Isolation of cardiomyocytes. Ventricular myocytes were isolated according to the method as described previously (33, 34) . For this purpose, male Sprague-Dawley rats (250 -300 g) were anesthetized with a mixture of ketamine (90 mg/kg) and xylazine (9 mg/kg). The hearts were quickly excised, mounted on the Langendorff apparatus, and perfused for 5 min with Ca 2ϩ -free buffer (pH 7.4) containing (in mM) 90 NaCl, 10 KCl, 1.2 KH2PO4, 5 MgSO4, 15 NaHCO3, 30 taurine, and 20 glucose and gassed with 95% O2-5% CO2 at 37°C. These hearts were then switched to the same perfusion medium containing 0.04% collagenase, 0.1% BSA, and 50 M CaCl2. At the end of a 30-min recirculation period, the hearts were removed from the cannula. The ventricles were cut into small pieces and subjected to another 15-min digestion in a fresh collagenase solution in the presence of 1% BSA gassed with a mixture of 95% O2-5% CO2 in a shaking water bath at 37°C. The ventricular fragments were triturated gently (twice per minute) with a plastic pipette. The cells from three to four harvests were combined and filtered through a 200-m nylon mesh. The myocytes were resuspended for 5 min in buffers containing gradually increasing extracellular Ca 2ϩ concentration (250, 500, 750 M) to a final concentration of 1 mM. The cell viability in all experimental groups was determined by using the trypan blue (SigmaAldrich, Oakville, Ontario, Canada) exclusion method. The unstained, stained, and total number of cells were counted by Neubauer chamber. The final cell suspension had 80 -85% viable cardiomyocytes, which were used for the measurement of fluorescence. All protocols were approved by the University of Manitoba Animal Care Committee in accordance with the standards of the Canadian Council on Animal Care.
Measurement of [Ca 2ϩ ]i. Freshly isolated cardiomyocytes were incubated with 5 M fura-2 AM for 40 min in a buffer (pH 7.4) containing (in mM) 90 NaCl, 10 KCl, 1.2 KH 2PO4, 5 MgSO4, 15 NaHCO3, 30 taurine, 20 glucose, 1 CaCl2, and 1% BSA. The cells were washed twice with the same solution to remove any extracellular dye. The final cell number in cuvette was adjusted to 0.3 million cells/ml for all the experimental groups. The alteration in fluorescence intensity was monitored by a SLM DMX-1100 dual-wavelength spectrofluorometer (SLM Instruments, Urbana, IL) adjusted to an excitation wavelength of 340/380 nm, emission wavelength of 510 nm, integration time of 0.95 s, and resolution time of 1.0 s. The [Ca 2ϩ ]i levels were calculated as described previously (24, 34) . Treatment with isoproterenol (100 M) was performed by incubating the fura-2 AM-loaded cells in a buffer containing isoproterenol for 5 min at room temperature before the measurement of fluorescence. Treatments with different pharmacological agents for the modulation of [Ca 2ϩ ]i were performed by incubating the fura-2 AM-loaded cells in the buffer containing the desired concentration of pharmacological agent for 10 min before the measurement of fluorescence; the cells were treated with ryanodine and cyclopiazonic acid (CPA) for 20 min before the determination of [Ca 2ϩ ]i. The concentrations of different pharmacological interventions for the present investigation were selected on the basis of our previous studies (24, 33, 34) . For examining the effect of low Na ϩ on catecholamine-mediated potentiation of [Ca 2ϩ ]i, cardiomyocytes were treated with Krebs-Henseleit (K-H) buffer (pH 7.4) containing 35 mM extracellular Na ϩ for 10 min at room temperature as described previously, and the osmolarity of the solution was maintained by adding choline chloride (24) . It is pointed out that no change in cell viability was observed under different incubation conditions. The increase in [Ca 2ϩ ]i at peak [Ca 2ϩ ]i was calculated as the net increase above the basal value in each experiment. The difference between the responses in the presence and absence of isoproterenol treatment was taken as the isoproterenolinduced increase in [Ca 2ϩ ]i. Isolated rat heart preparations. Isolated rat hearts were perfused with an oxygenated K-H solution at a flow of 10 ml/min (26, 27) . After stabilization for 20 min, a bolus injection of isoproterenol (1 M) was given to the hearts in the absence or presence of different concentrations of KB-R7943, an inhibitor of the Na ϩ /Ca 2ϩ exchanger (28) , and the left ventricular developed pressure (LVDP), as well as rates of pressure development and decay (ϮdP/dt), was measured by using a Biopac Data Acquisition System (Biopac Systems, Goleta, CA) as described previously (26, 27) . The concentrations of isoproterenol and KB-R7943 used in this study were selected on the basis of previous observations (19, 32) .
Statistical analysis. All results were expressed as means Ϯ SE. Statistical analysis was performed by using Microcal Origin version 6 (Microcal Software, Northampton, MA). The differences between two groups were evaluated by Student's t-test. The data from more than two groups were evaluated by one-way ANOVA followed by the Newman-Keuls test. Values showing P Ͻ 0.05 were considered statistically significant.
Drugs and chemicals. Verapamil, diltiazem, amiloride, nickel chloride, ouabain, CPA, ryanodine, sodium vanadate, isoproterenol, ATP, propranolol, EGTA, and BSA were purchased from Sigma Chemicals (St. Louis, MO). KB-R7943, fura-2 AM, and collagenase (type II, 295 U/mg) were purchased from Tocris Biosciences (Ellisville, MO), Molecular Probes (Eugene, OR), and Worthington Biochemical (Freehold, NJ), respectively. All other reagents were of analytical grade and purchased either from Sigma Chemicals or Fisher Scientific (Fair Lawn, NJ). (10, 25, 50 , and 100 M) revealed a concentrationdependent effect on the potentiation of ATP response; however, the maximal effect of isoproterenol treatment was seen at 100 M under in vitro experimental conditions employed in this study. These observations are in agreement with those reported in our previous studies (26, 27 (Table 2) . It is pointed out that the ATP-induced increase in control cardiomyocytes in this group was 21 Ϯ 3.4% higher than that of other experimental groups ( Table 2) . 1, 3) , the cells were exposed to 30 mM KCl, a known depolarizing agent, in the presence of low Na ϩ (35 mM). It can be seen from Fig. 6 that the KCl-mediated increase was further augmented in the presence of low Na ϩ ; this finding is in agreement with our previous observations (24) . In addition, the isoproterenol-induced increase in [Ca 2ϩ ] i in KCl-depolarized cardiomyocytes was potentiated by low Na ϩ (Fig. 6) (Table 4) .
RESULTS

Effect of ␤-AR stimulation on ATP-mediated intracellular
Incubation of cells for 20 min under control conditions required for experiments involving 20-min treatment with ryanodine or CPA instead of 10 min appears to be the reason for an increase in the sensitivity of control cardiomyocytes for ATP. Effects
Modification of positive inotropic effect of isoproterenol by inhibition of Na
ϩ /Ca 2ϩ exchanger. Treatment of the isolated heart with different concentrations of KB-R7943 was found to depress the LVDP (Table 5 ). The data in Table 5 show that the positive inotropic effect of isoproterenol measured in terms of an increase in LVDP was significantly depressed by treatment with different concentrations of KB-R7943. Likewise, the basal [Ca 2ϩ ] i as well as the increase in ϮdP/dt by isoproterenol were also depressed by KB-R7943 (data not shown). It is also pointed out that the positive inotropic effect of isoproterenol was completely blocked by 10 M propranolol (data not shown).
DISCUSSION
In the present study, we have shown that ATP causes an increase in [Ca 2ϩ ] i in isolated cardiomyocytes, an effect that was potentiated by treatment with isoproterenol. This finding is in agreement with previous observations (27, 37) . The isoproterenol-mediated increase in [Ca 2ϩ ] i , unlike that due to ATP, was markedly inhibited by propranolol, indicating the involvement of ␤-ARs in the isoproterenol-mediated increase in -pump ATPase, which is known to cause efflux of intracellular Ca 2ϩ (7) , in the ATP-mediated increase in [Ca 2ϩ ] i was apparent from the observation that low concentrations of vanadate (1 and 2 M), a SL Ca 2ϩ -pump ATPase blocker (29) , caused a significant elevation of the [Ca 2ϩ ] i . In contrast, the isoproterenol-mediated potentiation of the ATP-induced increase in [Ca 2ϩ ] i was attenuated by vanadate treatment. Because the level of [Ca 2ϩ ] i is determined by a balance between Ca 2ϩ influx and Ca 2ϩ efflux, and catecholamines are known to augment both these processes (7, 20) , the observed decrease in the potentiation of ATP-induced increase in ] i. The depressant effect of KB-R7943 on the basal cardiac function in the isolated rat heart is in agreement with a previous report (19) exchanger inhibitors like amiloride and Ni 2ϩ are known to depress both the transport modes of the exchanger (14, 18) . Additionally, isoproterenol has been shown to activate both the inward and outward current generated by Na ϩ /Ca 2ϩ exchanger (22) . Nonetheless, the results of the present study in terms of inhibition of isoproterenol response by a selective inhibitor of Ca 2ϩ entry mode of Na ϩ /Ca 2ϩ exchanger, KB-R7943, particularly when stimulated by low Na ϩ , indicate an important role of the reverse mode of Na ϩ /Ca 2ϩ exchanger in the catecholamine-mediated increase in [Ca 2ϩ ] i . Although the results in this study indicate that both SL L-type Ca 2ϩ channels and SL Na ϩ /Ca 2ϩ exchanger may participate in eliciting the isoproterenol-induced increase in [Ca 2ϩ ] i in isolated cardiomyocytes, the exact contribution of each site cannot be determined on the basis of pharmacological approaches employed here.
